Banka BioLoo Q2 Results FY27 Preview: Results Date, Expectations and the Numbers That Will Decide the September 2026 Quarter
- September 9, 2026
- Posted by: Harsh Piplani
- Category: Results
Banka BioLoo share price Rs 76.94 on 9 September 2026, down 2.73%. Q2 FY27 results date not confirmed. Q1 FY27 net profit Rs 0.04 crore loss. Q2 FY26 base a loss of Rs 1.08 crore.
Quick Answer
The Banka BioLoo Q2 results date for FY27 is not confirmed, and Banka BioLoo Ltd. had not filed a board meeting intimation with the NSE or BSE as of 9 September 2026. Indian listing rules require the September 2026 quarter results to be published within 45 days of the quarter end, an outer deadline of 14 November 2026. The quarter will be measured against a September 2025 base of Rs 13.01 crore in revenue and a loss of Rs 1.08 crore. This preview uses reported actuals only and carries no estimated revenue or profit figure for the coming quarter.
The Banka BioLoo Q2 results FY27 announcement is the next scheduled earnings event for Banka BioLoo Ltd., a sanitation company supplying bio-toilets, prefabricated toilet units and decentralised waste water treatment systems, largely to public sector and institutional buyers. The stock traded at Rs 76.94 on the NSE on 9 September 2026, down 2.73% from the previous close of Rs 79.10, about 21.4% below its 52-week high of Rs 97.88 and 87.7% above its 52-week low of Rs 41.00.
What makes the Banka BioLoo Q2 results print worth watching is the base it faces. The September 2025 quarter delivered Rs 13.01 crore of revenue and a loss of Rs 1.08 crore, while the most recent quarter on record, Q1 FY27, produced Rs 10.55 crore and a loss of Rs 0.04 crore. Everything below is built from those reported figures rather than from any forecast.
Click Here – Get Free Investment Predictions
When Is the Banka BioLoo Q2 Results FY27 Date?
The Banka BioLoo Q2 results date for FY27 is not confirmed. As of 9 September 2026, Banka BioLoo Ltd. had not filed a board meeting intimation with the NSE or BSE for the September 2026 quarter, so any date circulating before that filing appears should be treated as unverified.
What can be stated is the regulatory boundary. Listed companies in India must publish quarterly results within 45 days of the end of the quarter, which places the outer deadline for the September 2026 quarter at 14 November 2026. Companies also have to give the exchanges prior intimation of the board meeting that approves the results, so the Banka BioLoo Q2 results date becomes public through that filing rather than through any advance announcement.
The Banka BioLoo Q2 results FY27 print covers 1 July 2026 to 30 September 2026. Small and mid-cap companies more often report in the second half of that window than in the first, so late October or early November is the range to watch for Banka BioLoo.
Banka BioLoo Q2 Results Expectations: What the Market Is Actually Tracking
No verified analyst estimate for the Banka BioLoo Q2 results FY27 quarter is in the public domain, so no revenue or profit figure should be assumed for Banka BioLoo. The Banka BioLoo Q2 results watchlist below is built from what the company has actually reported and disclosed.
The first is revenue, which rose steadily from Rs 11.14 crore to Rs 17.67 crore over four quarters and then fell about 40% to Rs 10.55 crore in Q1 FY27. September 2025 brought Rs 13.01 crore, above the last reported quarter.
The second is the operating margin, which was negative 0.08% in September 2025 and 17.16% in Q1 FY27. The margin improved sharply even as the revenue line fell, which is the more interesting half of the last print.
The third is the tax line, which was negative in all five quarters at rates from negative 1.90% to negative 100%. Every quarter’s reported bottom line has therefore been helped by a credit rather than reduced by a charge.
Check Banka BioLoo Ltd. Live Fundamentals on the Univest Screener
Banka BioLoo Q2 Results Preview: The Q1 FY27 Actuals It Builds On
Banka BioLoo Ltd. reported revenue of Rs 10.55 crore in Q1 FY27, down 5.30% from Rs 11.14 crore in Q1 FY26, and a loss of Rs 0.04 crore at the net level, a swing from a profit of Rs 0.01 crore in Q1 FY26 to a loss of Rs 0.04 crore. These are reported actuals, not estimates.
Sequentially, revenue was down 40.29% over the March 2026 quarter figure of Rs 17.67 crore, and net profit was a swing from a profit of Rs 1.60 crore in Q4 FY26 to a loss of Rs 0.04 crore. Operating margin stood at 17.16% in Q1 FY27 against negative 0.08% in the September 2025 quarter, which is the comparison the Banka BioLoo Q2 results print will be read against.
Q2 FY26 Base: The Comparison Banka BioLoo Q2 Results FY27 Must Beat
Banka BioLoo Ltd. reported revenue of Rs 13.01 crore and a loss of Rs 1.08 crore in Q2 FY26, the September 2025 quarter. That is the year-ago base against which the September 2026 numbers will be judged, and it is the single most useful figure in this Banka BioLoo Q2 results preview.
Because the base quarter itself was loss-making, a year-on-year percentage comparison of profit is not meaningful for Banka BioLoo. The more useful test in the Banka BioLoo Q2 results print is whether the company reports a profit at all, and how the income line of Rs 13.01 crore compares with the Rs 10.55 crore of the June 2026 quarter.
Banka BioLoo Quarterly Results Trend Over the Last Four Quarters
| Quarter | Revenue (Rs Cr) | Net Profit (Rs Cr) |
|---|---|---|
| Q2 FY26 (Sep 2025) | 13.01 | (1.08) |
| Q3 FY26 (Dec 2025) | 15.26 | (0.13) |
| Q4 FY26 (Mar 2026) | 17.67 | 1.60 |
| Q1 FY27 (Jun 2026) | 10.55 | (0.04) |
Figures in brackets denote negative numbers. All four quarters above are reported actuals taken from the company’s exchange filings, and they are the only basis this Banka BioLoo Q2 results preview uses.
Revenue across those four quarters ranged from Rs 10.55 crore to Rs 17.67 crore, and net profit from Rs 1.08 crore loss to Rs 1.60 crore. That spread is the honest context for the Banka BioLoo Q2 results FY27 print, and it is why a single quarter should not be read as a trend on its own.
Key Factors That Could Shape Banka BioLoo Q2 Results FY27
The Banka BioLoo Q2 results outcome will turn on a small number of company-specific variables rather than on broad market conditions. The three below are the ones visible in what Banka BioLoo has already reported.
Public Sector Order Flow
Buyers are largely railways, municipal bodies and institutions, so revenue follows tender awards and installation schedules rather than a steady demand curve. That is why quarterly sales can fall 40% without any change in the underlying business.
Three of Five Quarters Were Losses
Net losses of Rs 1.08 crore, Rs 0.13 crore and Rs 0.04 crore appeared in three of the five quarters, with a Rs 1.60 crore profit in March 2026 and a Rs 0.01 crore result in June 2025. The company has not yet shown consecutive profitable quarters in this window.
Debt Roughly Equal to Net Worth
Borrowings of about Rs 40.8 crore sit against reserves of Rs 28.63 crore and equity capital of Rs 10.92 crore, a debt to equity ratio of 1.03. On operating profit of Rs 1.81 crore in the last quarter, the interest charge is a material claim on the result.
Banka BioLoo Q2 Results FY27: Share Price and Valuation Going Into the Print
Banka BioLoo share price today is Rs 76.94 on the NSE, down Rs 2.16 or 2.73% from the previous close of Rs 79.10 on 9 September 2026, ahead of the Banka BioLoo Q2 results announcement.
| Metric | Value (9 September 2026) |
|---|---|
| NSE Symbol | BANKA |
| Current Market Price | Rs 76.94 |
| 52-Week High | Rs 97.88 |
| 52-Week Low | Rs 41.00 |
| Market Capitalisation | Rs 84 crore |
| PE Ratio | 131.90 |
| PB Ratio | 2.13 |
| EPS (TTM) | Rs 0.58 |
| Book Value per Share | Rs 36.20 |
| Debt to Equity | 1.03 |
| Return on Equity | 1.74% |
| 50-Day Moving Average | Rs 85.43 |
| 200-Day Moving Average | Rs 73.50 |
| RSI (14) | 44.77 |
The stock trades below its 50-day average of Rs 85.43 but above its 200-day average of Rs 73.50, with a 14-day RSI of 44.77. None of this is a view on where the shares go once the Banka BioLoo Q2 results are announced, and no price target is offered here.
Download the Univest iOS App or Univest Android App to track Banka BioLoo Ltd. live price and quarterly earnings updates.
What Investors Should Watch When Banka BioLoo Q2 Results Are Announced
Four lines carry most of the information in a company of this size, and reading them in order keeps the Banka BioLoo Q2 results print in proportion.
- Revenue against the Rs 13.01 crore reported in the September 2025 base quarter
- Net profit against a loss of Rs 1.08 crore in that same quarter
- Operating margin against 17.16% in Q1 FY27
- Any exceptional item, provision or one-off gain disclosed alongside the numbers
A one-off gain or provision can move the reported profit far more than operations do in a company this size, which is why the Banka BioLoo Q2 results announcement should be read together with the notes to the results rather than the headline alone.
Conclusion on Banka BioLoo Q2 Results FY27
The Banka BioLoo Q2 results date is not confirmed, and 14 November 2026 is the statutory outer limit rather than an expected date. Banka BioLoo Ltd. will make the schedule public through a board meeting intimation to the exchanges, and until then the September 2026 quarter can only be framed by what has already been reported.
On that basis the Banka BioLoo Q2 results FY27 print faces a base of Rs 13.01 crore in revenue and a loss of Rs 1.08 crore, with the most recent quarter having delivered Rs 10.55 crore and a loss of Rs 0.04 crore. No numerical estimate appears in this preview because no verified consensus figure exists for Banka BioLoo, and readers should treat any preview that supplies one with caution. Verify every figure against the company filing on release and consult a SEBI-registered advisor before acting on quarterly earnings.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Banka BioLoo Q2 Results FY27
What is the Banka BioLoo Q2 results date for FY27?
Ans. The Banka BioLoo Q2 results date for FY27 is not confirmed. Banka BioLoo Ltd. had not filed a board meeting intimation with the NSE or BSE as of 9 September 2026. Indian listing rules require the September 2026 quarter results to be published by 14 November 2026 at the latest.
What quarter do the Banka BioLoo Q2 results 2026 cover?
Ans. The Banka BioLoo Q2 results FY27 cover 1 July 2026 to 30 September 2026, known as the September 2026 quarter. Banka BioLoo Ltd. reports revenue, operating profit and net profit for that period, and the Banka BioLoo Q2 results filing also carries the notes to the accounts.
What were the Banka BioLoo Q1 FY27 results?
Ans. Banka BioLoo Ltd. reported revenue of Rs 10.55 crore in Q1 FY27 and a loss of Rs 0.04 crore at the net level. Revenue was down 5.30% versus Q1 FY26 and net profit was a swing from a profit of Rs 0.01 crore in Q1 FY26 to a loss of Rs 0.04 crore.
What were Banka BioLoo Q2 FY26 results in the September 2025 quarter?
Ans. Banka BioLoo Ltd. reported revenue of Rs 13.01 crore and a loss of Rs 1.08 crore in Q2 FY26. Operating margin was negative 0.08%. Those figures form the base for the Banka BioLoo Q2 results FY27 comparison.
What are the main Banka BioLoo Q2 results expectations this quarter?
Ans. No verified analyst estimate is publicly available. The Banka BioLoo Q2 results expectations centre on revenue against the Rs 13.01 crore base, net profit against a loss of Rs 1.08 crore, operating margin against 17.16% in Q1 FY27, and any exceptional item disclosed with the numbers.
What is Banka BioLoo share price today ahead of the Q2 earnings?
Ans. Banka BioLoo share price is Rs 76.94 on the NSE as of 9 September 2026, down 2.73% from Rs 79.10. The stock is about 21.4% below its 52-week high of Rs 97.88 and 87.7% above its 52-week low of Rs 41.00, at a market capitalisation of Rs 84 crore.
Is Banka BioLoo a good stock to buy before the Q2 results?
Ans. This article does not offer a buy, sell or hold recommendation on Banka BioLoo Ltd. The stock trades at a price-to-book ratio of 2.13 with a return on equity of 1.74%. Assess the reported numbers when they are released and consult a SEBI-registered financial advisor before making any decision.
